Strategies using Off-Patent antibiotics for Methicillin-Resistant Staphylococcus aureus (“STOP MRSA”) – A Phase IIB, multi-center, randomized, double-blind clinical trial

Funding source : National Institutes of Health/ Division of Microbiologic and Infectious Diseases